PAR 2.00% 24.5¢ paradigm biopharmaceuticals limited..

where are we at at the moment ?, page-25

  1. 1,559 Posts.
    lightbulb Created with Sketch. 163
    If this has the massive potential some of you are
    predicting, why are so many of you worried about
    considerable further dilution. One thing that does
    concern me is the apparent “throw in the towel”
    attitude regarding royalties. I would hope that
    a 20% royalty would be at the bottom end of
    the negotiating range. Not 10-15%( if it is such
    a blockbuster). I still think there is a good
    .chance it will be. I postulated some figures about
    12 months ago, that by 2030 PAR shares could
    be worth $10-$240, based on DMOAD approval
    or not, 1-10% market penetration of TAM in
    high income nations, 20% royalty and 500M
    shares on issue. Would have to concede there
    may be well over that number of shares
    around by then.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.005(2.00%)
Mkt cap ! $85.7M
Open High Low Value Volume
25.0¢ 25.0¢ 24.5¢ $94.46K 380.3K

Buyers (Bids)

No. Vol. Price($)
5 92713 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36964 2
View Market Depth
Last trade - 16.10pm 06/06/2024 (20 minute delay) ?
Last
24.5¢
  Change
-0.005 ( 2.00 %)
Open High Low Volume
25.0¢ 25.0¢ 24.5¢ 91419
Last updated 15.19pm 06/06/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.